We expect to supplement clinical validation experiments and establish animal models to confirm the authenticity and reliability of the study results in humans, clarify the effect of SLC3A2 on tumor progression in vivo, and further explore the specific mechanism of action of SLC3A2 in tumor progression. Here, SLC3A2 is linked to neoplasm.